Latest filing published 12 Jul 2022 for Lucira Health, Inc., €5,379.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Tamanna Prashar: trading record in brief
Tamanna Prashar (chief executive) discloses dealings in Lucira Health, Inc. to SEC (Form 4). Over a trading history stretching from 10 March 2021 to 8 July 2022, the count stands at 8 filings.
On the market, this insider has only sold: 3 sales, €6,439 in total. Other entries cover 1 share grant and 4 option exercises. 2022 to date brings no purchases and 3 sales.
The latest filing, published on 12 July 2022, reports an open-market sale of €446 in Lucira Health, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Tamanna Prashar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,289 shares@ US$4.689.1% of flowCommon StockSEC:0001209191-22-041963:0
- 79,484 shares@ US$0.8290.9% of flowCommon StockSEC:0001209191-22-009441:0
2 of 2 declarations
